Credo Biomedical
Credo Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases, animal health, and human wellness. At Credo Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world.
Industries
Nr. of Employees
small (1-50)
Products
VitaPCR™
A portable real-time PCR system delivering molecular diagnostic results in approximately 20 minutes at the point of care.
VitaSIRO solo™
A molecular diagnostic platform for point-of-need testing offering assays for infectious diseases and genetic markers.
VitaDataLink™
A data management and triage system that supports rapid clinical decision-making at the point of care.
QubeMDx+™
A veterinary molecular diagnostic platform offering assays such as avian sexing and respiratory pathogen detection.
VitaPCR™
A portable real-time PCR system delivering molecular diagnostic results in approximately 20 minutes at the point of care.
VitaSIRO solo™
A molecular diagnostic platform for point-of-need testing offering assays for infectious diseases and genetic markers.
VitaDataLink™
A data management and triage system that supports rapid clinical decision-making at the point of care.
QubeMDx+™
A veterinary molecular diagnostic platform offering assays such as avian sexing and respiratory pathogen detection.